Gene study for newborns with HIE on cooling therapy
Part of Brain & nervous system, Heart & circulation clinical trials.
This study uses whole genome sequencing to look at the genes of newborns with HIE (brain injury from lack of oxygen) who are receiving cooling treatment. The goal is to learn more about how genes may affect recovery and outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Baby must be born at 35 weeks of pregnancy or later
- Baby has been diagnosed with moderate or severe HIE (a type of brain injury from lack of oxygen) or HIE with seizures
- Baby is currently receiving total body cooling (therapeutic hypothermia)
- Baby is in the NICU at Texas Children's Hospital Main, West, or Woodlands
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether cooling a newborn's body after a difficult birth helps prevent brain damage. Researchers will track babies treated with this cooling therapy and use brain imaging to see how well it works.
This trial is for newborn babies who had an oxygen shortage around birth and now have severe brain injury. It aims to test approaches that may help improve outcomes after this kind of early-life brain damage.
This study looks at a blood test that might help check brain injury in newborns who had a lack of oxygen at birth. The test could give doctors more information to help care for your baby.
This study looks at how children who had a brain injury around birth (called hypoxic-ischaemic encephalopathy, or HIE) are doing in school and daily life, compared to children without that history. It aims to understand the long-term effects and support needs.
This study looks at newborns who had a difficult start due to oxygen loss around birth (called hypoxic ischemic encephalopathy). Researchers want to learn more about this condition to improve care and outcomes for affected babies.
This trial studies whether RLS-0071 is safe and can help some newborns with moderate or severe hypoxic-ischemic encephalopathy (HIE), a brain injury caused by low oxygen around birth. Babies in the study also receive standard whole-body cooling (therapeutic hypothermia), and the researchers will watch for side effects and early signs of benefit.
Hear when a new Hypoxic Ischemic Encephalopathy of Newborn trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.